A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)

Clinical trial NCT03333018 · COMPLETED

Trial details

NCT number: NCT03333018
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2015-07-06
Primary completion: 2017-02-28
Enrollment: 22155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.